Global Sepsis Detection Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Sepsis Detection Kit market size was valued at US$ 850 million in 2025 and is forecast to a readjusted size of US$ 1500 million by 2032 with a CAGR of 8.4% during review period.
Sepsis Detection Kits are reagents, cartridges, reaction boxes, and disposable testing consumables that use human whole blood, serum, plasma, positive blood culture samples, or other clinical samples as the detection targets. They employ immunoassay, chemiluminescence, fluorescence immunoassay, polymerase chain reaction, real-time reverse transcription PCR, multiplex molecular detection, microfluidics, magnetic resonance imaging, mass spectrometry sample pretreatment, leukocyte biophysical analysis, or other in vitro diagnostic techniques to qualitatively or quantitatively analyze host response markers, gene expression characteristics, immune cell status, bacterial or fungal nucleic acids, and drug resistance genes related to sepsis.
Key Findings: Global sepsis cases estimated at 48.9 million annually; Blood culture remains core for pathogen identification; Procalcitonin supports routine risk assessment; Mature molecular panel analyzes 43 targets per hour; Host response detection differentiates infectious inflammation. Industry Trends: The sepsis diagnostic kit market is evolving from single-marker detection and traditional culture-dependent diagnostic processes to a multi-layered diagnostic pathway integrating host response assessment, rapid pathogen identification, and drug resistance information. Procalcitonin remains a mature tool for bacterial infection and sepsis risk assessment, while novel gene expression detection helps differentiate between infectious and non-infectious systemic inflammation by analyzing patient immune responses. Molecular panel analysis is simultaneously expanding target coverage and shortening reporting time; cartridge systems can identify multiple bacteria, yeasts, and drug resistance genes within approximately one hour after a positive blood culture. Direct whole blood testing technology is another important development direction, reducing reliance on positive blood cultures for specific pathogens. Product upgrades also include reduced sample size, automated pretreatment, sealed consumables, simplified result interpretation, and deep integration with hospital antimicrobial management processes. In the long term, the market trend is not towards a single, universal test, but rather towards a tiered diagnostic system comprised of rapid screening, risk stratification, etiological confirmation, and treatment guidance.
The fundamental driver of demand for sepsis diagnostic kits stems from the high disease burden and rapidly progressing clinical characteristics. Global health agencies estimate that tens of millions of people develop sepsis each year, and if identification and treatment are delayed, patients can rapidly progress to septic shock, multiple organ failure, and even death. Hospitals are therefore continuously strengthening standardized sepsis management programs, emergency assessment procedures, and laboratory testing pathways, promoting the standardized application of blood cultures, lactate, and other auxiliary tests. Biomarker kits can support early assessment of bacterial infection and disease progression risk, while molecular assay panels can shorten the time from a positive sample to obtaining actionable pathogen information. Increased requirements for antimicrobial management are also a significant driver; bacterial infection identification, pathogen recognition, and resistance biomarker detection help to initiate, adjust, or discontinue antimicrobial therapy more promptly within validated clinical pathways.
Limitations
The market remains limited by the biological heterogeneity of sepsis and the lack of a single, independent diagnostic test. Biomarker levels can be influenced by infection severity, sampling time, underlying diseases, surgery, trauma, and other inflammatory states, and therefore must be interpreted in conjunction with clinical assessment and supplemental laboratory results. Molecular pathogen panels have well-defined target ranges and cannot identify pathogens or resistance mechanisms outside the testing menu; some products also rely on positive blood cultures, limiting the extent to which overall diagnostic time can be reduced. Direct whole blood testing and host response testing can reduce some procedural delays, but typically require specialized equipment, trained personnel, quality control systems, and clinically validated result interpretation rules. Equipment investment, per-test consumable costs, regulatory requirements, and insufficient laboratory infrastructure also limit their adoption in resource-constrained healthcare systems.
Market Opportunities: The most attractive opportunities lie in technologies that can shorten the time lag between clinically suspected sepsis and access to actionable laboratory information. Direct whole blood pathogen testing can overcome some limitations of culture-dependent testing, while host response gene expression testing can help differentiate sepsis from non-infectious systemic inflammation when the pathogen is not yet identified. There is further room for development in broader multiplex pathogen panels, resistance gene coverage, pediatric and neonatal applications, in-hospital decentralized testing, and software-aided interpretation of test results in conjunction with clinical variables. The market, with its inadequate blood culture infrastructure, has a long-standing need for affordable, simplified, and reliable near-patient testing products. Suppliers capable of demonstrating clinical efficacy, rapid reporting, low manual intervention, and compatibility with existing laboratory platforms have a greater opportunity to extend beyond simple reagent sales to comprehensive hospital sepsis management processes.
Industry Risks and Challenges The core challenge in the industry lies in translating stable analytical performance into clinical benefits across different patient populations and healthcare scenarios. Sepsis presentation varies significantly depending on infection site, pathogen type, age, immune status, and disease stage, making the establishment of uniform thresholds and universal detection algorithms more complex. Manufacturers need to validate product performance in representative patient populations, control contamination and cross-reactivity, and clarify the impact of negative, positive, or indeterminate results on subsequent testing. Molecular assays also need to address issues such as off-panel pathogens, inactive nucleic acids, and the inability of specific resistance markers to cover all resistance mechanisms. Hospitals face the challenge of integrating rapid results into emergency, intensive care, and antibiotic management processes. Regulatory approvals, health economics evidence, payment mechanisms, equipment standardization, and post-market quality monitoring will continue to impact product commercialization.
Supply Chain Analysis: The upstream of the sepsis testing kit supply chain mainly includes antibodies, antigens, enzymes, primers, probes, reference materials, calibrators, quality control materials, magnetic particles, membrane materials, microfluidic components, and medical-grade plastics. Biomarker immunoassays highly rely on antibody specificity, calibration consistency, and stable detection chemistry systems; molecular products require reliable nucleic acid extraction, amplification reagents, target design, and contamination control. Host reaction assays further increase requirements for RNA stability, gene expression normalization, and algorithm development. Equipment cartridges and sealed reagent kits also involve precision injection molding, lyophilization processes, fluid control components, and validated packaging systems. Because sepsis testing is conducted in highly time-sensitive clinical settings, supplier certification, batch consistency, cold chain management, and raw material traceability directly affect product reliability and regulatory compliance.
The midstream value creation segment encompasses biomarker screening, assay design, clinical validation, reagent formulation, cartridge manufacturing, software development, regulatory registration, and integration with diagnostic equipment. Higher value-added capabilities in the industry typically lie in proprietary biomarkers or target combinations, clinically validated algorithms, automated sample input and output processes, and established analytical platforms. Downstream demand primarily comes from hospital laboratories, emergency departments, intensive care units, infectious disease departments, and central laboratories. Distributors and local service providers handle equipment deployment, reagent supply, training, and maintenance. Profitability depends not only on reagent production costs but also on clinical evidence, regulatory status, breadth of assays, repurchase of consumables, equipment utilization, and the product's integration into existing hospital diagnostic workflows.
Segmented Market Analysis: Biomarker-based reagent kits represent a highly commercialized segment, deployable on widely installed immunoassay and clinical biochemistry platforms. Procalcitonin plays a crucial role in bacterial infection assessment, sepsis progression risk assessment, and antimicrobial management pathways. Its main advantages lie in providing standardized quantitative results, relatively short testing times, and compatibility with routine serum or plasma testing procedures. However, biomarkers primarily reflect host responses and cannot directly identify pathogenic agents; therefore, continuous monitoring and comprehensive clinical interpretation remain crucial. Other inflammation or organ function-related indicators can supplement the diagnostic pathway, but their performance and role vary across patient populations and clinical procedures.
Molecular pathogen panels represent a major technological upgrade direction, enabling significantly faster identification of multiple bloodstream pathogens and specific drug resistance genes than traditional identification methods after a positive blood culture. Direct whole blood testing can further shorten the diagnostic pathway by targeting specific targets, but its detection range is still limited by the included species and biomarkers. Host response gene expression kits represent a smaller, emerging segment; their differentiating value lies in estimating the likelihood of sepsis by measuring the patient's immune response, rather than simply identifying microbial targets. Commercial opportunities across different technology segments are gradually shifting towards combined detection strategies: biomarkers support early risk assessment, host response testing supports differential diagnosis, and pathogen panels provide etiological and drug resistance information.
Downstream Market Opportunities: Hospital emergency and critical care pathways constitute core downstream opportunities due to the highly time-sensitive nature of diagnostic decisions and the frequent need for repeated testing. Emergency departments require rapid tools for triaging suspected infected patients, while intensive care units need risk stratification, continuous monitoring, and decision support for antimicrobial therapy. Clinical microbiology laboratories are increasingly focusing on multiplex panels that reduce manual identification steps and provide pathogen and resistance information in a standardized format. New application opportunities are also emerging in pediatric and neonatal care, postoperative monitoring, immunocompromised patients, and regional hospitals seeking simplified sample input and output systems. Commercially valuable products need to be compatible with existing sample workflows, provide interpretable results within the clinical decision window, and effectively complement blood cultures, clinical biochemistry, and microbiological testing, rather than simply repeating existing processes.
Regional Analysis: North America is a region with a relatively mature commercialization of sepsis diagnostic kits, primarily due to well-developed hospital laboratory infrastructure, relatively standardized sepsis management programs, and regulatory pathways covering biomarkers, molecular pathogens, and host response testing. Approved procalcitonin assays, blood culture identification panels, direct whole blood molecular assays, and host response products collectively form a diverse technological landscape. Market adoption is increasingly driven by clinical utility, integration of antimicrobial administration, payment terms, and the ability to improve laboratory and patient management efficiency, rather than simply the novelty of analytical technologies. Europe, also a mature market with a strong foundation in immunoassays and molecular diagnostic platforms, faces challenges in commercialization due to differences in procurement, payment, and regulatory implementation across countries.
The Asia-Pacific, Latin America, Middle East, and Africa regions have significant unmet diagnostic needs, but these markets exhibit marked differences in laboratory capabilities, testing accessibility, and affordability. Higher patient numbers and severe infection burdens create a demand for rapid diagnostics, while insufficient microbiology laboratory infrastructure in some regions increases the focus on automated, stable, and low-complexity systems. Products with shorter turnaround times, stable consumable supplies, and the ability to fit regional hospital budgets have greater expansion potential, but business models must cover equipment deployment, service networks, personnel training, and local regulatory registration. Therefore, this report argues that regional growth potential depends not only on clinical demand but also on laboratory readiness and the ability of suppliers to establish sustainable distribution and technical support systems.
Competitive Landscape: The sepsis testing kit market exhibits a stratified competitive structure, rather than a single, homogeneous product market. Large in vitro diagnostic (IVD) companies compete primarily by leveraging their extensive equipment infrastructure, automated immunoassay assays, regulatory experience, and established reagent supply relationships with hospital laboratories. Molecular diagnostic specialists differentiate themselves through multi-target coverage, rapid cartridge workflows, pathogen and resistance gene assays, and simplified sample input and output procedures. Emerging host response and direct whole blood assay companies focus on addressing diagnostic needs not yet fully met by traditional biomarkers and culture-dependent panel assays. Competitive advantage depends on clinical validation, time-to-result, analytical reliability, breadth of assays, equipment accessibility, regulatory approval, evidence of antimicrobial administration, and integration with hospital information and treatment workflows. Price competition remains important, but hospitals must also consider equipment utilization, staff time, repeat testing, service support, and the impact of delayed or ambiguous results.
Global Sepsis Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sepsis Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sepsis Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
Chapter 2, to profile the top manufacturers of Sepsis Detection Kit, with price, sales quantity, revenue, and global market share of Sepsis Detection Kit from 2021 to 2026.
Chapter 3, the Sepsis Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sepsis Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sepsis Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sepsis Detection Kit.
Chapter 14 and 15, to describe Sepsis Detection Kit sales channel, distributors, customers, research findings and conclusion.
Sepsis Detection Kits are reagents, cartridges, reaction boxes, and disposable testing consumables that use human whole blood, serum, plasma, positive blood culture samples, or other clinical samples as the detection targets. They employ immunoassay, chemiluminescence, fluorescence immunoassay, polymerase chain reaction, real-time reverse transcription PCR, multiplex molecular detection, microfluidics, magnetic resonance imaging, mass spectrometry sample pretreatment, leukocyte biophysical analysis, or other in vitro diagnostic techniques to qualitatively or quantitatively analyze host response markers, gene expression characteristics, immune cell status, bacterial or fungal nucleic acids, and drug resistance genes related to sepsis.
Key Findings: Global sepsis cases estimated at 48.9 million annually; Blood culture remains core for pathogen identification; Procalcitonin supports routine risk assessment; Mature molecular panel analyzes 43 targets per hour; Host response detection differentiates infectious inflammation. Industry Trends: The sepsis diagnostic kit market is evolving from single-marker detection and traditional culture-dependent diagnostic processes to a multi-layered diagnostic pathway integrating host response assessment, rapid pathogen identification, and drug resistance information. Procalcitonin remains a mature tool for bacterial infection and sepsis risk assessment, while novel gene expression detection helps differentiate between infectious and non-infectious systemic inflammation by analyzing patient immune responses. Molecular panel analysis is simultaneously expanding target coverage and shortening reporting time; cartridge systems can identify multiple bacteria, yeasts, and drug resistance genes within approximately one hour after a positive blood culture. Direct whole blood testing technology is another important development direction, reducing reliance on positive blood cultures for specific pathogens. Product upgrades also include reduced sample size, automated pretreatment, sealed consumables, simplified result interpretation, and deep integration with hospital antimicrobial management processes. In the long term, the market trend is not towards a single, universal test, but rather towards a tiered diagnostic system comprised of rapid screening, risk stratification, etiological confirmation, and treatment guidance.
Market Dynamics
Driven FactorsThe fundamental driver of demand for sepsis diagnostic kits stems from the high disease burden and rapidly progressing clinical characteristics. Global health agencies estimate that tens of millions of people develop sepsis each year, and if identification and treatment are delayed, patients can rapidly progress to septic shock, multiple organ failure, and even death. Hospitals are therefore continuously strengthening standardized sepsis management programs, emergency assessment procedures, and laboratory testing pathways, promoting the standardized application of blood cultures, lactate, and other auxiliary tests. Biomarker kits can support early assessment of bacterial infection and disease progression risk, while molecular assay panels can shorten the time from a positive sample to obtaining actionable pathogen information. Increased requirements for antimicrobial management are also a significant driver; bacterial infection identification, pathogen recognition, and resistance biomarker detection help to initiate, adjust, or discontinue antimicrobial therapy more promptly within validated clinical pathways.
Limitations
The market remains limited by the biological heterogeneity of sepsis and the lack of a single, independent diagnostic test. Biomarker levels can be influenced by infection severity, sampling time, underlying diseases, surgery, trauma, and other inflammatory states, and therefore must be interpreted in conjunction with clinical assessment and supplemental laboratory results. Molecular pathogen panels have well-defined target ranges and cannot identify pathogens or resistance mechanisms outside the testing menu; some products also rely on positive blood cultures, limiting the extent to which overall diagnostic time can be reduced. Direct whole blood testing and host response testing can reduce some procedural delays, but typically require specialized equipment, trained personnel, quality control systems, and clinically validated result interpretation rules. Equipment investment, per-test consumable costs, regulatory requirements, and insufficient laboratory infrastructure also limit their adoption in resource-constrained healthcare systems.
Market Opportunities: The most attractive opportunities lie in technologies that can shorten the time lag between clinically suspected sepsis and access to actionable laboratory information. Direct whole blood pathogen testing can overcome some limitations of culture-dependent testing, while host response gene expression testing can help differentiate sepsis from non-infectious systemic inflammation when the pathogen is not yet identified. There is further room for development in broader multiplex pathogen panels, resistance gene coverage, pediatric and neonatal applications, in-hospital decentralized testing, and software-aided interpretation of test results in conjunction with clinical variables. The market, with its inadequate blood culture infrastructure, has a long-standing need for affordable, simplified, and reliable near-patient testing products. Suppliers capable of demonstrating clinical efficacy, rapid reporting, low manual intervention, and compatibility with existing laboratory platforms have a greater opportunity to extend beyond simple reagent sales to comprehensive hospital sepsis management processes.
Industry Risks and Challenges The core challenge in the industry lies in translating stable analytical performance into clinical benefits across different patient populations and healthcare scenarios. Sepsis presentation varies significantly depending on infection site, pathogen type, age, immune status, and disease stage, making the establishment of uniform thresholds and universal detection algorithms more complex. Manufacturers need to validate product performance in representative patient populations, control contamination and cross-reactivity, and clarify the impact of negative, positive, or indeterminate results on subsequent testing. Molecular assays also need to address issues such as off-panel pathogens, inactive nucleic acids, and the inability of specific resistance markers to cover all resistance mechanisms. Hospitals face the challenge of integrating rapid results into emergency, intensive care, and antibiotic management processes. Regulatory approvals, health economics evidence, payment mechanisms, equipment standardization, and post-market quality monitoring will continue to impact product commercialization.
Supply Chain Analysis: The upstream of the sepsis testing kit supply chain mainly includes antibodies, antigens, enzymes, primers, probes, reference materials, calibrators, quality control materials, magnetic particles, membrane materials, microfluidic components, and medical-grade plastics. Biomarker immunoassays highly rely on antibody specificity, calibration consistency, and stable detection chemistry systems; molecular products require reliable nucleic acid extraction, amplification reagents, target design, and contamination control. Host reaction assays further increase requirements for RNA stability, gene expression normalization, and algorithm development. Equipment cartridges and sealed reagent kits also involve precision injection molding, lyophilization processes, fluid control components, and validated packaging systems. Because sepsis testing is conducted in highly time-sensitive clinical settings, supplier certification, batch consistency, cold chain management, and raw material traceability directly affect product reliability and regulatory compliance.
The midstream value creation segment encompasses biomarker screening, assay design, clinical validation, reagent formulation, cartridge manufacturing, software development, regulatory registration, and integration with diagnostic equipment. Higher value-added capabilities in the industry typically lie in proprietary biomarkers or target combinations, clinically validated algorithms, automated sample input and output processes, and established analytical platforms. Downstream demand primarily comes from hospital laboratories, emergency departments, intensive care units, infectious disease departments, and central laboratories. Distributors and local service providers handle equipment deployment, reagent supply, training, and maintenance. Profitability depends not only on reagent production costs but also on clinical evidence, regulatory status, breadth of assays, repurchase of consumables, equipment utilization, and the product's integration into existing hospital diagnostic workflows.
Segmented Market Analysis: Biomarker-based reagent kits represent a highly commercialized segment, deployable on widely installed immunoassay and clinical biochemistry platforms. Procalcitonin plays a crucial role in bacterial infection assessment, sepsis progression risk assessment, and antimicrobial management pathways. Its main advantages lie in providing standardized quantitative results, relatively short testing times, and compatibility with routine serum or plasma testing procedures. However, biomarkers primarily reflect host responses and cannot directly identify pathogenic agents; therefore, continuous monitoring and comprehensive clinical interpretation remain crucial. Other inflammation or organ function-related indicators can supplement the diagnostic pathway, but their performance and role vary across patient populations and clinical procedures.
Molecular pathogen panels represent a major technological upgrade direction, enabling significantly faster identification of multiple bloodstream pathogens and specific drug resistance genes than traditional identification methods after a positive blood culture. Direct whole blood testing can further shorten the diagnostic pathway by targeting specific targets, but its detection range is still limited by the included species and biomarkers. Host response gene expression kits represent a smaller, emerging segment; their differentiating value lies in estimating the likelihood of sepsis by measuring the patient's immune response, rather than simply identifying microbial targets. Commercial opportunities across different technology segments are gradually shifting towards combined detection strategies: biomarkers support early risk assessment, host response testing supports differential diagnosis, and pathogen panels provide etiological and drug resistance information.
Downstream Market Opportunities: Hospital emergency and critical care pathways constitute core downstream opportunities due to the highly time-sensitive nature of diagnostic decisions and the frequent need for repeated testing. Emergency departments require rapid tools for triaging suspected infected patients, while intensive care units need risk stratification, continuous monitoring, and decision support for antimicrobial therapy. Clinical microbiology laboratories are increasingly focusing on multiplex panels that reduce manual identification steps and provide pathogen and resistance information in a standardized format. New application opportunities are also emerging in pediatric and neonatal care, postoperative monitoring, immunocompromised patients, and regional hospitals seeking simplified sample input and output systems. Commercially valuable products need to be compatible with existing sample workflows, provide interpretable results within the clinical decision window, and effectively complement blood cultures, clinical biochemistry, and microbiological testing, rather than simply repeating existing processes.
Regional Analysis: North America is a region with a relatively mature commercialization of sepsis diagnostic kits, primarily due to well-developed hospital laboratory infrastructure, relatively standardized sepsis management programs, and regulatory pathways covering biomarkers, molecular pathogens, and host response testing. Approved procalcitonin assays, blood culture identification panels, direct whole blood molecular assays, and host response products collectively form a diverse technological landscape. Market adoption is increasingly driven by clinical utility, integration of antimicrobial administration, payment terms, and the ability to improve laboratory and patient management efficiency, rather than simply the novelty of analytical technologies. Europe, also a mature market with a strong foundation in immunoassays and molecular diagnostic platforms, faces challenges in commercialization due to differences in procurement, payment, and regulatory implementation across countries.
The Asia-Pacific, Latin America, Middle East, and Africa regions have significant unmet diagnostic needs, but these markets exhibit marked differences in laboratory capabilities, testing accessibility, and affordability. Higher patient numbers and severe infection burdens create a demand for rapid diagnostics, while insufficient microbiology laboratory infrastructure in some regions increases the focus on automated, stable, and low-complexity systems. Products with shorter turnaround times, stable consumable supplies, and the ability to fit regional hospital budgets have greater expansion potential, but business models must cover equipment deployment, service networks, personnel training, and local regulatory registration. Therefore, this report argues that regional growth potential depends not only on clinical demand but also on laboratory readiness and the ability of suppliers to establish sustainable distribution and technical support systems.
Competitive Landscape: The sepsis testing kit market exhibits a stratified competitive structure, rather than a single, homogeneous product market. Large in vitro diagnostic (IVD) companies compete primarily by leveraging their extensive equipment infrastructure, automated immunoassay assays, regulatory experience, and established reagent supply relationships with hospital laboratories. Molecular diagnostic specialists differentiate themselves through multi-target coverage, rapid cartridge workflows, pathogen and resistance gene assays, and simplified sample input and output procedures. Emerging host response and direct whole blood assay companies focus on addressing diagnostic needs not yet fully met by traditional biomarkers and culture-dependent panel assays. Competitive advantage depends on clinical validation, time-to-result, analytical reliability, breadth of assays, equipment accessibility, regulatory approval, evidence of antimicrobial administration, and integration with hospital information and treatment workflows. Price competition remains important, but hospitals must also consider equipment utilization, staff time, repeat testing, service support, and the impact of delayed or ambiguous results.
Report Scope
This report is a detailed and comprehensive analysis for global Sepsis Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.Key Features:
Global Sepsis Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032Global Sepsis Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sepsis Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sepsis Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Sepsis Detection Kit
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
- This report profiles key players in the global Sepsis Detection Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioM?rieux SA, Roche Holding Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, DiaSorin S.p.A., QuidelOrtho Corporation, PHC Holdings Corporation, Sysmex Corporation, Bruker Corporation, etc.
- This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
- Sepsis Detection Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immunochromatography
- Molecular Biology
Market segment by Detection Target
- Single Biomarker
- Multi-indicator Combined Detection
Market segment by Detection Time
- ≤30 minutes
- 0.5~4 hours
- ≥4 hours
Market segment by Application
- General Hospitals
- Medical Laboratory (ICL) Industry
- Maternal and Child Health Industry
- Others
- Major players covered
- BioM?rieux SA
- Roche Holding Ltd
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Siemens Healthineers AG
- DiaSorin S.p.A.
- QuidelOrtho Corporation
- PHC Holdings Corporation
- Sysmex Corporation
- Bruker Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- T2 Biosystems, Inc.
- Guangzhou Wondfo Biotech Co., Ltd.
- Getein Biotech, Inc.
- Boditech Med Inc.
- SD Biosensor, Inc.
- Cytovale, Inc.
- Immunexpress Pty Ltd
- Inflammatix, Inc.
- QIAGEN N.V.
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Sepsis Detection Kit product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top manufacturers of Sepsis Detection Kit, with price, sales quantity, revenue, and global market share of Sepsis Detection Kit from 2021 to 2026.
Chapter 3, the Sepsis Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sepsis Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sepsis Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sepsis Detection Kit.
Chapter 14 and 15, to describe Sepsis Detection Kit sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Sepsis Detection Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Immunochromatography
1.3.3 Molecular Biology
1.4 Market Analysis by Detection Target
1.4.1 Overview: Global Sepsis Detection Kit Consumption Value by Detection Target: 2021 Versus 2025 Versus 2032
1.4.2 Single Biomarker
1.4.3 Multi-indicator Combined Detection
1.5 Market Analysis by Detection Time
1.5.1 Overview: Global Sepsis Detection Kit Consumption Value by Detection Time: 2021 Versus 2025 Versus 2032
1.5.2 ≤30 minutes
1.5.3 0.5~4 hours
1.5.4 ≥4 hours
1.6 Market Analysis by Application
1.6.1 Overview: Global Sepsis Detection Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 General Hospitals
1.6.3 Medical Laboratory (ICL) Industry
1.6.4 Maternal and Child Health Industry
1.6.5 Others
1.7 Global Sepsis Detection Kit Market Size & Forecast
1.7.1 Global Sepsis Detection Kit Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Sepsis Detection Kit Sales Quantity (2021-2032)
1.7.3 Global Sepsis Detection Kit Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 BioM?rieux SA
2.1.1 BioM?rieux SA Details
2.1.2 BioM?rieux SA Major Business
2.1.3 BioM?rieux SA Sepsis Detection Kit Product and Services
2.1.4 BioM?rieux SA Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BioM?rieux SA Recent Developments/Updates
2.2 Roche Holding Ltd
2.2.1 Roche Holding Ltd Details
2.2.2 Roche Holding Ltd Major Business
2.2.3 Roche Holding Ltd Sepsis Detection Kit Product and Services
2.2.4 Roche Holding Ltd Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Roche Holding Ltd Recent Developments/Updates
2.3 Thermo Fisher Scientific Inc.
2.3.1 Thermo Fisher Scientific Inc. Details
2.3.2 Thermo Fisher Scientific Inc. Major Business
2.3.3 Thermo Fisher Scientific Inc. Sepsis Detection Kit Product and Services
2.3.4 Thermo Fisher Scientific Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business
2.4.3 Abbott Laboratories Sepsis Detection Kit Product and Services
2.4.4 Abbott Laboratories Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Abbott Laboratories Recent Developments/Updates
2.5 Siemens Healthineers AG
2.5.1 Siemens Healthineers AG Details
2.5.2 Siemens Healthineers AG Major Business
2.5.3 Siemens Healthineers AG Sepsis Detection Kit Product and Services
2.5.4 Siemens Healthineers AG Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Siemens Healthineers AG Recent Developments/Updates
2.6 DiaSorin S.p.A.
2.6.1 DiaSorin S.p.A. Details
2.6.2 DiaSorin S.p.A. Major Business
2.6.3 DiaSorin S.p.A. Sepsis Detection Kit Product and Services
2.6.4 DiaSorin S.p.A. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 DiaSorin S.p.A. Recent Developments/Updates
2.7 QuidelOrtho Corporation
2.7.1 QuidelOrtho Corporation Details
2.7.2 QuidelOrtho Corporation Major Business
2.7.3 QuidelOrtho Corporation Sepsis Detection Kit Product and Services
2.7.4 QuidelOrtho Corporation Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 QuidelOrtho Corporation Recent Developments/Updates
2.8 PHC Holdings Corporation
2.8.1 PHC Holdings Corporation Details
2.8.2 PHC Holdings Corporation Major Business
2.8.3 PHC Holdings Corporation Sepsis Detection Kit Product and Services
2.8.4 PHC Holdings Corporation Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 PHC Holdings Corporation Recent Developments/Updates
2.9 Sysmex Corporation
2.9.1 Sysmex Corporation Details
2.9.2 Sysmex Corporation Major Business
2.9.3 Sysmex Corporation Sepsis Detection Kit Product and Services
2.9.4 Sysmex Corporation Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Sysmex Corporation Recent Developments/Updates
2.10 Bruker Corporation
2.10.1 Bruker Corporation Details
2.10.2 Bruker Corporation Major Business
2.10.3 Bruker Corporation Sepsis Detection Kit Product and Services
2.10.4 Bruker Corporation Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Bruker Corporation Recent Developments/Updates
2.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
2.11.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Details
2.11.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
2.11.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Product and Services
2.11.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
2.12 T2 Biosystems, Inc.
2.12.1 T2 Biosystems, Inc. Details
2.12.2 T2 Biosystems, Inc. Major Business
2.12.3 T2 Biosystems, Inc. Sepsis Detection Kit Product and Services
2.12.4 T2 Biosystems, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 T2 Biosystems, Inc. Recent Developments/Updates
2.13 Guangzhou Wondfo Biotech Co., Ltd.
2.13.1 Guangzhou Wondfo Biotech Co., Ltd. Details
2.13.2 Guangzhou Wondfo Biotech Co., Ltd. Major Business
2.13.3 Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Product and Services
2.13.4 Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
2.14 Getein Biotech, Inc.
2.14.1 Getein Biotech, Inc. Details
2.14.2 Getein Biotech, Inc. Major Business
2.14.3 Getein Biotech, Inc. Sepsis Detection Kit Product and Services
2.14.4 Getein Biotech, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Getein Biotech, Inc. Recent Developments/Updates
2.15 Boditech Med Inc.
2.15.1 Boditech Med Inc. Details
2.15.2 Boditech Med Inc. Major Business
2.15.3 Boditech Med Inc. Sepsis Detection Kit Product and Services
2.15.4 Boditech Med Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Boditech Med Inc. Recent Developments/Updates
2.16 SD Biosensor, Inc.
2.16.1 SD Biosensor, Inc. Details
2.16.2 SD Biosensor, Inc. Major Business
2.16.3 SD Biosensor, Inc. Sepsis Detection Kit Product and Services
2.16.4 SD Biosensor, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 SD Biosensor, Inc. Recent Developments/Updates
2.17 Cytovale, Inc.
2.17.1 Cytovale, Inc. Details
2.17.2 Cytovale, Inc. Major Business
2.17.3 Cytovale, Inc. Sepsis Detection Kit Product and Services
2.17.4 Cytovale, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Cytovale, Inc. Recent Developments/Updates
2.18 Immunexpress Pty Ltd
2.18.1 Immunexpress Pty Ltd Details
2.18.2 Immunexpress Pty Ltd Major Business
2.18.3 Immunexpress Pty Ltd Sepsis Detection Kit Product and Services
2.18.4 Immunexpress Pty Ltd Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Immunexpress Pty Ltd Recent Developments/Updates
2.19 Inflammatix, Inc.
2.19.1 Inflammatix, Inc. Details
2.19.2 Inflammatix, Inc. Major Business
2.19.3 Inflammatix, Inc. Sepsis Detection Kit Product and Services
2.19.4 Inflammatix, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Inflammatix, Inc. Recent Developments/Updates
2.20 QIAGEN N.V.
2.20.1 QIAGEN N.V. Details
2.20.2 QIAGEN N.V. Major Business
2.20.3 QIAGEN N.V. Sepsis Detection Kit Product and Services
2.20.4 QIAGEN N.V. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 QIAGEN N.V. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SEPSIS DETECTION KIT BY MANUFACTURER
3.1 Global Sepsis Detection Kit Sales Quantity by Manufacturer (2021-2026)
3.2 Global Sepsis Detection Kit Revenue by Manufacturer (2021-2026)
3.3 Global Sepsis Detection Kit Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Sepsis Detection Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Sepsis Detection Kit Manufacturer Market Share in 2025
3.4.3 Top 6 Sepsis Detection Kit Manufacturer Market Share in 2025
3.5 Sepsis Detection Kit Market: Overall Company Footprint Analysis
3.5.1 Sepsis Detection Kit Market: Region Footprint
3.5.2 Sepsis Detection Kit Market: Company Product Type Footprint
3.5.3 Sepsis Detection Kit Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Sepsis Detection Kit Market Size by Region
4.1.1 Global Sepsis Detection Kit Sales Quantity by Region (2021-2032)
4.1.2 Global Sepsis Detection Kit Consumption Value by Region (2021-2032)
4.1.3 Global Sepsis Detection Kit Average Price by Region (2021-2032)
4.2 North America Sepsis Detection Kit Consumption Value (2021-2032)
4.3 Europe Sepsis Detection Kit Consumption Value (2021-2032)
4.4 Asia-Pacific Sepsis Detection Kit Consumption Value (2021-2032)
4.5 South America Sepsis Detection Kit Consumption Value (2021-2032)
4.6 Middle East & Africa Sepsis Detection Kit Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Sepsis Detection Kit Sales Quantity by Type (2021-2032)
5.2 Global Sepsis Detection Kit Consumption Value by Type (2021-2032)
5.3 Global Sepsis Detection Kit Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Sepsis Detection Kit Sales Quantity by Application (2021-2032)
6.2 Global Sepsis Detection Kit Consumption Value by Application (2021-2032)
6.3 Global Sepsis Detection Kit Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Sepsis Detection Kit Sales Quantity by Type (2021-2032)
7.2 North America Sepsis Detection Kit Sales Quantity by Application (2021-2032)
7.3 North America Sepsis Detection Kit Market Size by Country
7.3.1 North America Sepsis Detection Kit Sales Quantity by Country (2021-2032)
7.3.2 North America Sepsis Detection Kit Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Sepsis Detection Kit Sales Quantity by Type (2021-2032)
8.2 Europe Sepsis Detection Kit Sales Quantity by Application (2021-2032)
8.3 Europe Sepsis Detection Kit Market Size by Country
8.3.1 Europe Sepsis Detection Kit Sales Quantity by Country (2021-2032)
8.3.2 Europe Sepsis Detection Kit Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Sepsis Detection Kit Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Sepsis Detection Kit Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Sepsis Detection Kit Market Size by Region
9.3.1 Asia-Pacific Sepsis Detection Kit Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Sepsis Detection Kit Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Sepsis Detection Kit Sales Quantity by Type (2021-2032)
10.2 South America Sepsis Detection Kit Sales Quantity by Application (2021-2032)
10.3 South America Sepsis Detection Kit Market Size by Country
10.3.1 South America Sepsis Detection Kit Sales Quantity by Country (2021-2032)
10.3.2 South America Sepsis Detection Kit Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Sepsis Detection Kit Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Sepsis Detection Kit Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Sepsis Detection Kit Market Size by Country
11.3.1 Middle East & Africa Sepsis Detection Kit Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Sepsis Detection Kit Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Sepsis Detection Kit Market Drivers
12.2 Sepsis Detection Kit Market Restraints
12.3 Sepsis Detection Kit Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Sepsis Detection Kit and Key Manufacturers
13.2 Manufacturing Costs Percentage of Sepsis Detection Kit
13.3 Sepsis Detection Kit Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Sepsis Detection Kit Typical Distributors
14.3 Sepsis Detection Kit Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Sepsis Detection Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Immunochromatography
1.3.3 Molecular Biology
1.4 Market Analysis by Detection Target
1.4.1 Overview: Global Sepsis Detection Kit Consumption Value by Detection Target: 2021 Versus 2025 Versus 2032
1.4.2 Single Biomarker
1.4.3 Multi-indicator Combined Detection
1.5 Market Analysis by Detection Time
1.5.1 Overview: Global Sepsis Detection Kit Consumption Value by Detection Time: 2021 Versus 2025 Versus 2032
1.5.2 ≤30 minutes
1.5.3 0.5~4 hours
1.5.4 ≥4 hours
1.6 Market Analysis by Application
1.6.1 Overview: Global Sepsis Detection Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 General Hospitals
1.6.3 Medical Laboratory (ICL) Industry
1.6.4 Maternal and Child Health Industry
1.6.5 Others
1.7 Global Sepsis Detection Kit Market Size & Forecast
1.7.1 Global Sepsis Detection Kit Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Sepsis Detection Kit Sales Quantity (2021-2032)
1.7.3 Global Sepsis Detection Kit Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 BioM?rieux SA
2.1.1 BioM?rieux SA Details
2.1.2 BioM?rieux SA Major Business
2.1.3 BioM?rieux SA Sepsis Detection Kit Product and Services
2.1.4 BioM?rieux SA Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BioM?rieux SA Recent Developments/Updates
2.2 Roche Holding Ltd
2.2.1 Roche Holding Ltd Details
2.2.2 Roche Holding Ltd Major Business
2.2.3 Roche Holding Ltd Sepsis Detection Kit Product and Services
2.2.4 Roche Holding Ltd Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Roche Holding Ltd Recent Developments/Updates
2.3 Thermo Fisher Scientific Inc.
2.3.1 Thermo Fisher Scientific Inc. Details
2.3.2 Thermo Fisher Scientific Inc. Major Business
2.3.3 Thermo Fisher Scientific Inc. Sepsis Detection Kit Product and Services
2.3.4 Thermo Fisher Scientific Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business
2.4.3 Abbott Laboratories Sepsis Detection Kit Product and Services
2.4.4 Abbott Laboratories Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Abbott Laboratories Recent Developments/Updates
2.5 Siemens Healthineers AG
2.5.1 Siemens Healthineers AG Details
2.5.2 Siemens Healthineers AG Major Business
2.5.3 Siemens Healthineers AG Sepsis Detection Kit Product and Services
2.5.4 Siemens Healthineers AG Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Siemens Healthineers AG Recent Developments/Updates
2.6 DiaSorin S.p.A.
2.6.1 DiaSorin S.p.A. Details
2.6.2 DiaSorin S.p.A. Major Business
2.6.3 DiaSorin S.p.A. Sepsis Detection Kit Product and Services
2.6.4 DiaSorin S.p.A. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 DiaSorin S.p.A. Recent Developments/Updates
2.7 QuidelOrtho Corporation
2.7.1 QuidelOrtho Corporation Details
2.7.2 QuidelOrtho Corporation Major Business
2.7.3 QuidelOrtho Corporation Sepsis Detection Kit Product and Services
2.7.4 QuidelOrtho Corporation Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 QuidelOrtho Corporation Recent Developments/Updates
2.8 PHC Holdings Corporation
2.8.1 PHC Holdings Corporation Details
2.8.2 PHC Holdings Corporation Major Business
2.8.3 PHC Holdings Corporation Sepsis Detection Kit Product and Services
2.8.4 PHC Holdings Corporation Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 PHC Holdings Corporation Recent Developments/Updates
2.9 Sysmex Corporation
2.9.1 Sysmex Corporation Details
2.9.2 Sysmex Corporation Major Business
2.9.3 Sysmex Corporation Sepsis Detection Kit Product and Services
2.9.4 Sysmex Corporation Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Sysmex Corporation Recent Developments/Updates
2.10 Bruker Corporation
2.10.1 Bruker Corporation Details
2.10.2 Bruker Corporation Major Business
2.10.3 Bruker Corporation Sepsis Detection Kit Product and Services
2.10.4 Bruker Corporation Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Bruker Corporation Recent Developments/Updates
2.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
2.11.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Details
2.11.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
2.11.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Product and Services
2.11.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
2.12 T2 Biosystems, Inc.
2.12.1 T2 Biosystems, Inc. Details
2.12.2 T2 Biosystems, Inc. Major Business
2.12.3 T2 Biosystems, Inc. Sepsis Detection Kit Product and Services
2.12.4 T2 Biosystems, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 T2 Biosystems, Inc. Recent Developments/Updates
2.13 Guangzhou Wondfo Biotech Co., Ltd.
2.13.1 Guangzhou Wondfo Biotech Co., Ltd. Details
2.13.2 Guangzhou Wondfo Biotech Co., Ltd. Major Business
2.13.3 Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Product and Services
2.13.4 Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
2.14 Getein Biotech, Inc.
2.14.1 Getein Biotech, Inc. Details
2.14.2 Getein Biotech, Inc. Major Business
2.14.3 Getein Biotech, Inc. Sepsis Detection Kit Product and Services
2.14.4 Getein Biotech, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Getein Biotech, Inc. Recent Developments/Updates
2.15 Boditech Med Inc.
2.15.1 Boditech Med Inc. Details
2.15.2 Boditech Med Inc. Major Business
2.15.3 Boditech Med Inc. Sepsis Detection Kit Product and Services
2.15.4 Boditech Med Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Boditech Med Inc. Recent Developments/Updates
2.16 SD Biosensor, Inc.
2.16.1 SD Biosensor, Inc. Details
2.16.2 SD Biosensor, Inc. Major Business
2.16.3 SD Biosensor, Inc. Sepsis Detection Kit Product and Services
2.16.4 SD Biosensor, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 SD Biosensor, Inc. Recent Developments/Updates
2.17 Cytovale, Inc.
2.17.1 Cytovale, Inc. Details
2.17.2 Cytovale, Inc. Major Business
2.17.3 Cytovale, Inc. Sepsis Detection Kit Product and Services
2.17.4 Cytovale, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Cytovale, Inc. Recent Developments/Updates
2.18 Immunexpress Pty Ltd
2.18.1 Immunexpress Pty Ltd Details
2.18.2 Immunexpress Pty Ltd Major Business
2.18.3 Immunexpress Pty Ltd Sepsis Detection Kit Product and Services
2.18.4 Immunexpress Pty Ltd Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Immunexpress Pty Ltd Recent Developments/Updates
2.19 Inflammatix, Inc.
2.19.1 Inflammatix, Inc. Details
2.19.2 Inflammatix, Inc. Major Business
2.19.3 Inflammatix, Inc. Sepsis Detection Kit Product and Services
2.19.4 Inflammatix, Inc. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Inflammatix, Inc. Recent Developments/Updates
2.20 QIAGEN N.V.
2.20.1 QIAGEN N.V. Details
2.20.2 QIAGEN N.V. Major Business
2.20.3 QIAGEN N.V. Sepsis Detection Kit Product and Services
2.20.4 QIAGEN N.V. Sepsis Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 QIAGEN N.V. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SEPSIS DETECTION KIT BY MANUFACTURER
3.1 Global Sepsis Detection Kit Sales Quantity by Manufacturer (2021-2026)
3.2 Global Sepsis Detection Kit Revenue by Manufacturer (2021-2026)
3.3 Global Sepsis Detection Kit Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Sepsis Detection Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Sepsis Detection Kit Manufacturer Market Share in 2025
3.4.3 Top 6 Sepsis Detection Kit Manufacturer Market Share in 2025
3.5 Sepsis Detection Kit Market: Overall Company Footprint Analysis
3.5.1 Sepsis Detection Kit Market: Region Footprint
3.5.2 Sepsis Detection Kit Market: Company Product Type Footprint
3.5.3 Sepsis Detection Kit Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Sepsis Detection Kit Market Size by Region
4.1.1 Global Sepsis Detection Kit Sales Quantity by Region (2021-2032)
4.1.2 Global Sepsis Detection Kit Consumption Value by Region (2021-2032)
4.1.3 Global Sepsis Detection Kit Average Price by Region (2021-2032)
4.2 North America Sepsis Detection Kit Consumption Value (2021-2032)
4.3 Europe Sepsis Detection Kit Consumption Value (2021-2032)
4.4 Asia-Pacific Sepsis Detection Kit Consumption Value (2021-2032)
4.5 South America Sepsis Detection Kit Consumption Value (2021-2032)
4.6 Middle East & Africa Sepsis Detection Kit Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Sepsis Detection Kit Sales Quantity by Type (2021-2032)
5.2 Global Sepsis Detection Kit Consumption Value by Type (2021-2032)
5.3 Global Sepsis Detection Kit Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Sepsis Detection Kit Sales Quantity by Application (2021-2032)
6.2 Global Sepsis Detection Kit Consumption Value by Application (2021-2032)
6.3 Global Sepsis Detection Kit Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Sepsis Detection Kit Sales Quantity by Type (2021-2032)
7.2 North America Sepsis Detection Kit Sales Quantity by Application (2021-2032)
7.3 North America Sepsis Detection Kit Market Size by Country
7.3.1 North America Sepsis Detection Kit Sales Quantity by Country (2021-2032)
7.3.2 North America Sepsis Detection Kit Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Sepsis Detection Kit Sales Quantity by Type (2021-2032)
8.2 Europe Sepsis Detection Kit Sales Quantity by Application (2021-2032)
8.3 Europe Sepsis Detection Kit Market Size by Country
8.3.1 Europe Sepsis Detection Kit Sales Quantity by Country (2021-2032)
8.3.2 Europe Sepsis Detection Kit Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Sepsis Detection Kit Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Sepsis Detection Kit Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Sepsis Detection Kit Market Size by Region
9.3.1 Asia-Pacific Sepsis Detection Kit Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Sepsis Detection Kit Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Sepsis Detection Kit Sales Quantity by Type (2021-2032)
10.2 South America Sepsis Detection Kit Sales Quantity by Application (2021-2032)
10.3 South America Sepsis Detection Kit Market Size by Country
10.3.1 South America Sepsis Detection Kit Sales Quantity by Country (2021-2032)
10.3.2 South America Sepsis Detection Kit Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Sepsis Detection Kit Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Sepsis Detection Kit Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Sepsis Detection Kit Market Size by Country
11.3.1 Middle East & Africa Sepsis Detection Kit Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Sepsis Detection Kit Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Sepsis Detection Kit Market Drivers
12.2 Sepsis Detection Kit Market Restraints
12.3 Sepsis Detection Kit Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Sepsis Detection Kit and Key Manufacturers
13.2 Manufacturing Costs Percentage of Sepsis Detection Kit
13.3 Sepsis Detection Kit Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Sepsis Detection Kit Typical Distributors
14.3 Sepsis Detection Kit Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Sepsis Detection Kit Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Sepsis Detection Kit Consumption Value by Detection Target, (USD Million), 2021 & 2025 & 2032
Table 3. Global Sepsis Detection Kit Consumption Value by Detection Time, (USD Million), 2021 & 2025 & 2032
Table 4. Global Sepsis Detection Kit Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. BioM?rieux SA Basic Information, Manufacturing Base and Competitors
Table 6. BioM?rieux SA Major Business
Table 7. BioM?rieux SA Sepsis Detection Kit Product and Services
Table 8. BioM?rieux SA Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. BioM?rieux SA Recent Developments/Updates
Table 10. Roche Holding Ltd Basic Information, Manufacturing Base and Competitors
Table 11. Roche Holding Ltd Major Business
Table 12. Roche Holding Ltd Sepsis Detection Kit Product and Services
Table 13. Roche Holding Ltd Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Roche Holding Ltd Recent Developments/Updates
Table 15. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Thermo Fisher Scientific Inc. Major Business
Table 17. Thermo Fisher Scientific Inc. Sepsis Detection Kit Product and Services
Table 18. Thermo Fisher Scientific Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 20. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 21. Abbott Laboratories Major Business
Table 22. Abbott Laboratories Sepsis Detection Kit Product and Services
Table 23. Abbott Laboratories Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Abbott Laboratories Recent Developments/Updates
Table 25. Siemens Healthineers AG Basic Information, Manufacturing Base and Competitors
Table 26. Siemens Healthineers AG Major Business
Table 27. Siemens Healthineers AG Sepsis Detection Kit Product and Services
Table 28. Siemens Healthineers AG Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Siemens Healthineers AG Recent Developments/Updates
Table 30. DiaSorin S.p.A. Basic Information, Manufacturing Base and Competitors
Table 31. DiaSorin S.p.A. Major Business
Table 32. DiaSorin S.p.A. Sepsis Detection Kit Product and Services
Table 33. DiaSorin S.p.A. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. DiaSorin S.p.A. Recent Developments/Updates
Table 35. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 36. QuidelOrtho Corporation Major Business
Table 37. QuidelOrtho Corporation Sepsis Detection Kit Product and Services
Table 38. QuidelOrtho Corporation Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. QuidelOrtho Corporation Recent Developments/Updates
Table 40. PHC Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 41. PHC Holdings Corporation Major Business
Table 42. PHC Holdings Corporation Sepsis Detection Kit Product and Services
Table 43. PHC Holdings Corporation Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. PHC Holdings Corporation Recent Developments/Updates
Table 45. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 46. Sysmex Corporation Major Business
Table 47. Sysmex Corporation Sepsis Detection Kit Product and Services
Table 48. Sysmex Corporation Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Sysmex Corporation Recent Developments/Updates
Table 50. Bruker Corporation Basic Information, Manufacturing Base and Competitors
Table 51. Bruker Corporation Major Business
Table 52. Bruker Corporation Sepsis Detection Kit Product and Services
Table 53. Bruker Corporation Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Bruker Corporation Recent Developments/Updates
Table 55. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 56. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
Table 57. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Product and Services
Table 58. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
Table 60. T2 Biosystems, Inc. Basic Information, Manufacturing Base and Competitors
Table 61. T2 Biosystems, Inc. Major Business
Table 62. T2 Biosystems, Inc. Sepsis Detection Kit Product and Services
Table 63. T2 Biosystems, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. T2 Biosystems, Inc. Recent Developments/Updates
Table 65. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 66. Guangzhou Wondfo Biotech Co., Ltd. Major Business
Table 67. Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Product and Services
Table 68. Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
Table 70. Getein Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 71. Getein Biotech, Inc. Major Business
Table 72. Getein Biotech, Inc. Sepsis Detection Kit Product and Services
Table 73. Getein Biotech, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Getein Biotech, Inc. Recent Developments/Updates
Table 75. Boditech Med Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Boditech Med Inc. Major Business
Table 77. Boditech Med Inc. Sepsis Detection Kit Product and Services
Table 78. Boditech Med Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Boditech Med Inc. Recent Developments/Updates
Table 80. SD Biosensor, Inc. Basic Information, Manufacturing Base and Competitors
Table 81. SD Biosensor, Inc. Major Business
Table 82. SD Biosensor, Inc. Sepsis Detection Kit Product and Services
Table 83. SD Biosensor, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. SD Biosensor, Inc. Recent Developments/Updates
Table 85. Cytovale, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Cytovale, Inc. Major Business
Table 87. Cytovale, Inc. Sepsis Detection Kit Product and Services
Table 88. Cytovale, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Cytovale, Inc. Recent Developments/Updates
Table 90. Immunexpress Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 91. Immunexpress Pty Ltd Major Business
Table 92. Immunexpress Pty Ltd Sepsis Detection Kit Product and Services
Table 93. Immunexpress Pty Ltd Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Immunexpress Pty Ltd Recent Developments/Updates
Table 95. Inflammatix, Inc. Basic Information, Manufacturing Base and Competitors
Table 96. Inflammatix, Inc. Major Business
Table 97. Inflammatix, Inc. Sepsis Detection Kit Product and Services
Table 98. Inflammatix, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Inflammatix, Inc. Recent Developments/Updates
Table 100. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 101. QIAGEN N.V. Major Business
Table 102. QIAGEN N.V. Sepsis Detection Kit Product and Services
Table 103. QIAGEN N.V. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. QIAGEN N.V. Recent Developments/Updates
Table 105. Global Sepsis Detection Kit Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 106. Global Sepsis Detection Kit Revenue by Manufacturer (2021-2026) & (USD Million)
Table 107. Global Sepsis Detection Kit Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 108. Market Position of Manufacturers in Sepsis Detection Kit, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 109. Head Office and Sepsis Detection Kit Production Site of Key Manufacturer
Table 110. Sepsis Detection Kit Market: Company Product Type Footprint
Table 111. Sepsis Detection Kit Market: Company Product Application Footprint
Table 112. Sepsis Detection Kit New Market Entrants and Barriers to Market Entry
Table 113. Sepsis Detection Kit Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Sepsis Detection Kit Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 115. Global Sepsis Detection Kit Sales Quantity by Region (2021-2026) & (K Units)
Table 116. Global Sepsis Detection Kit Sales Quantity by Region (2027-2032) & (K Units)
Table 117. Global Sepsis Detection Kit Consumption Value by Region (2021-2026) & (USD Million)
Table 118. Global Sepsis Detection Kit Consumption Value by Region (2027-2032) & (USD Million)
Table 119. Global Sepsis Detection Kit Average Price by Region (2021-2026) & (US$/Unit)
Table 120. Global Sepsis Detection Kit Average Price by Region (2027-2032) & (US$/Unit)
Table 121. Global Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 122. Global Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 123. Global Sepsis Detection Kit Consumption Value by Type (2021-2026) & (USD Million)
Table 124. Global Sepsis Detection Kit Consumption Value by Type (2027-2032) & (USD Million)
Table 125. Global Sepsis Detection Kit Average Price by Type (2021-2026) & (US$/Unit)
Table 126. Global Sepsis Detection Kit Average Price by Type (2027-2032) & (US$/Unit)
Table 127. Global Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 128. Global Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 129. Global Sepsis Detection Kit Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Global Sepsis Detection Kit Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Global Sepsis Detection Kit Average Price by Application (2021-2026) & (US$/Unit)
Table 132. Global Sepsis Detection Kit Average Price by Application (2027-2032) & (US$/Unit)
Table 133. North America Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 134. North America Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 135. North America Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 136. North America Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 137. North America Sepsis Detection Kit Sales Quantity by Country (2021-2026) & (K Units)
Table 138. North America Sepsis Detection Kit Sales Quantity by Country (2027-2032) & (K Units)
Table 139. North America Sepsis Detection Kit Consumption Value by Country (2021-2026) & (USD Million)
Table 140. North America Sepsis Detection Kit Consumption Value by Country (2027-2032) & (USD Million)
Table 141. Europe Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 142. Europe Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 143. Europe Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 144. Europe Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 145. Europe Sepsis Detection Kit Sales Quantity by Country (2021-2026) & (K Units)
Table 146. Europe Sepsis Detection Kit Sales Quantity by Country (2027-2032) & (K Units)
Table 147. Europe Sepsis Detection Kit Consumption Value by Country (2021-2026) & (USD Million)
Table 148. Europe Sepsis Detection Kit Consumption Value by Country (2027-2032) & (USD Million)
Table 149. Asia-Pacific Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 150. Asia-Pacific Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 151. Asia-Pacific Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 152. Asia-Pacific Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 153. Asia-Pacific Sepsis Detection Kit Sales Quantity by Region (2021-2026) & (K Units)
Table 154. Asia-Pacific Sepsis Detection Kit Sales Quantity by Region (2027-2032) & (K Units)
Table 155. Asia-Pacific Sepsis Detection Kit Consumption Value by Region (2021-2026) & (USD Million)
Table 156. Asia-Pacific Sepsis Detection Kit Consumption Value by Region (2027-2032) & (USD Million)
Table 157. South America Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 158. South America Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 159. South America Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 160. South America Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 161. South America Sepsis Detection Kit Sales Quantity by Country (2021-2026) & (K Units)
Table 162. South America Sepsis Detection Kit Sales Quantity by Country (2027-2032) & (K Units)
Table 163. South America Sepsis Detection Kit Consumption Value by Country (2021-2026) & (USD Million)
Table 164. South America Sepsis Detection Kit Consumption Value by Country (2027-2032) & (USD Million)
Table 165. Middle East & Africa Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 166. Middle East & Africa Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 167. Middle East & Africa Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 168. Middle East & Africa Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 169. Middle East & Africa Sepsis Detection Kit Sales Quantity by Country (2021-2026) & (K Units)
Table 170. Middle East & Africa Sepsis Detection Kit Sales Quantity by Country (2027-2032) & (K Units)
Table 171. Middle East & Africa Sepsis Detection Kit Consumption Value by Country (2021-2026) & (USD Million)
Table 172. Middle East & Africa Sepsis Detection Kit Consumption Value by Country (2027-2032) & (USD Million)
Table 173. Sepsis Detection Kit Raw Material
Table 174. Key Manufacturers of Sepsis Detection Kit Raw Materials
Table 175. Sepsis Detection Kit Typical Distributors
Table 176. Sepsis Detection Kit Typical Customers
Table 1. Global Sepsis Detection Kit Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Sepsis Detection Kit Consumption Value by Detection Target, (USD Million), 2021 & 2025 & 2032
Table 3. Global Sepsis Detection Kit Consumption Value by Detection Time, (USD Million), 2021 & 2025 & 2032
Table 4. Global Sepsis Detection Kit Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. BioM?rieux SA Basic Information, Manufacturing Base and Competitors
Table 6. BioM?rieux SA Major Business
Table 7. BioM?rieux SA Sepsis Detection Kit Product and Services
Table 8. BioM?rieux SA Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. BioM?rieux SA Recent Developments/Updates
Table 10. Roche Holding Ltd Basic Information, Manufacturing Base and Competitors
Table 11. Roche Holding Ltd Major Business
Table 12. Roche Holding Ltd Sepsis Detection Kit Product and Services
Table 13. Roche Holding Ltd Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Roche Holding Ltd Recent Developments/Updates
Table 15. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Thermo Fisher Scientific Inc. Major Business
Table 17. Thermo Fisher Scientific Inc. Sepsis Detection Kit Product and Services
Table 18. Thermo Fisher Scientific Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 20. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 21. Abbott Laboratories Major Business
Table 22. Abbott Laboratories Sepsis Detection Kit Product and Services
Table 23. Abbott Laboratories Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Abbott Laboratories Recent Developments/Updates
Table 25. Siemens Healthineers AG Basic Information, Manufacturing Base and Competitors
Table 26. Siemens Healthineers AG Major Business
Table 27. Siemens Healthineers AG Sepsis Detection Kit Product and Services
Table 28. Siemens Healthineers AG Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Siemens Healthineers AG Recent Developments/Updates
Table 30. DiaSorin S.p.A. Basic Information, Manufacturing Base and Competitors
Table 31. DiaSorin S.p.A. Major Business
Table 32. DiaSorin S.p.A. Sepsis Detection Kit Product and Services
Table 33. DiaSorin S.p.A. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. DiaSorin S.p.A. Recent Developments/Updates
Table 35. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 36. QuidelOrtho Corporation Major Business
Table 37. QuidelOrtho Corporation Sepsis Detection Kit Product and Services
Table 38. QuidelOrtho Corporation Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. QuidelOrtho Corporation Recent Developments/Updates
Table 40. PHC Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 41. PHC Holdings Corporation Major Business
Table 42. PHC Holdings Corporation Sepsis Detection Kit Product and Services
Table 43. PHC Holdings Corporation Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. PHC Holdings Corporation Recent Developments/Updates
Table 45. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 46. Sysmex Corporation Major Business
Table 47. Sysmex Corporation Sepsis Detection Kit Product and Services
Table 48. Sysmex Corporation Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Sysmex Corporation Recent Developments/Updates
Table 50. Bruker Corporation Basic Information, Manufacturing Base and Competitors
Table 51. Bruker Corporation Major Business
Table 52. Bruker Corporation Sepsis Detection Kit Product and Services
Table 53. Bruker Corporation Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Bruker Corporation Recent Developments/Updates
Table 55. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 56. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
Table 57. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Product and Services
Table 58. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
Table 60. T2 Biosystems, Inc. Basic Information, Manufacturing Base and Competitors
Table 61. T2 Biosystems, Inc. Major Business
Table 62. T2 Biosystems, Inc. Sepsis Detection Kit Product and Services
Table 63. T2 Biosystems, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. T2 Biosystems, Inc. Recent Developments/Updates
Table 65. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 66. Guangzhou Wondfo Biotech Co., Ltd. Major Business
Table 67. Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Product and Services
Table 68. Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
Table 70. Getein Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 71. Getein Biotech, Inc. Major Business
Table 72. Getein Biotech, Inc. Sepsis Detection Kit Product and Services
Table 73. Getein Biotech, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Getein Biotech, Inc. Recent Developments/Updates
Table 75. Boditech Med Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Boditech Med Inc. Major Business
Table 77. Boditech Med Inc. Sepsis Detection Kit Product and Services
Table 78. Boditech Med Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Boditech Med Inc. Recent Developments/Updates
Table 80. SD Biosensor, Inc. Basic Information, Manufacturing Base and Competitors
Table 81. SD Biosensor, Inc. Major Business
Table 82. SD Biosensor, Inc. Sepsis Detection Kit Product and Services
Table 83. SD Biosensor, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. SD Biosensor, Inc. Recent Developments/Updates
Table 85. Cytovale, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Cytovale, Inc. Major Business
Table 87. Cytovale, Inc. Sepsis Detection Kit Product and Services
Table 88. Cytovale, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Cytovale, Inc. Recent Developments/Updates
Table 90. Immunexpress Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 91. Immunexpress Pty Ltd Major Business
Table 92. Immunexpress Pty Ltd Sepsis Detection Kit Product and Services
Table 93. Immunexpress Pty Ltd Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Immunexpress Pty Ltd Recent Developments/Updates
Table 95. Inflammatix, Inc. Basic Information, Manufacturing Base and Competitors
Table 96. Inflammatix, Inc. Major Business
Table 97. Inflammatix, Inc. Sepsis Detection Kit Product and Services
Table 98. Inflammatix, Inc. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Inflammatix, Inc. Recent Developments/Updates
Table 100. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 101. QIAGEN N.V. Major Business
Table 102. QIAGEN N.V. Sepsis Detection Kit Product and Services
Table 103. QIAGEN N.V. Sepsis Detection Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. QIAGEN N.V. Recent Developments/Updates
Table 105. Global Sepsis Detection Kit Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 106. Global Sepsis Detection Kit Revenue by Manufacturer (2021-2026) & (USD Million)
Table 107. Global Sepsis Detection Kit Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 108. Market Position of Manufacturers in Sepsis Detection Kit, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 109. Head Office and Sepsis Detection Kit Production Site of Key Manufacturer
Table 110. Sepsis Detection Kit Market: Company Product Type Footprint
Table 111. Sepsis Detection Kit Market: Company Product Application Footprint
Table 112. Sepsis Detection Kit New Market Entrants and Barriers to Market Entry
Table 113. Sepsis Detection Kit Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Sepsis Detection Kit Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 115. Global Sepsis Detection Kit Sales Quantity by Region (2021-2026) & (K Units)
Table 116. Global Sepsis Detection Kit Sales Quantity by Region (2027-2032) & (K Units)
Table 117. Global Sepsis Detection Kit Consumption Value by Region (2021-2026) & (USD Million)
Table 118. Global Sepsis Detection Kit Consumption Value by Region (2027-2032) & (USD Million)
Table 119. Global Sepsis Detection Kit Average Price by Region (2021-2026) & (US$/Unit)
Table 120. Global Sepsis Detection Kit Average Price by Region (2027-2032) & (US$/Unit)
Table 121. Global Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 122. Global Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 123. Global Sepsis Detection Kit Consumption Value by Type (2021-2026) & (USD Million)
Table 124. Global Sepsis Detection Kit Consumption Value by Type (2027-2032) & (USD Million)
Table 125. Global Sepsis Detection Kit Average Price by Type (2021-2026) & (US$/Unit)
Table 126. Global Sepsis Detection Kit Average Price by Type (2027-2032) & (US$/Unit)
Table 127. Global Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 128. Global Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 129. Global Sepsis Detection Kit Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Global Sepsis Detection Kit Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Global Sepsis Detection Kit Average Price by Application (2021-2026) & (US$/Unit)
Table 132. Global Sepsis Detection Kit Average Price by Application (2027-2032) & (US$/Unit)
Table 133. North America Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 134. North America Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 135. North America Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 136. North America Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 137. North America Sepsis Detection Kit Sales Quantity by Country (2021-2026) & (K Units)
Table 138. North America Sepsis Detection Kit Sales Quantity by Country (2027-2032) & (K Units)
Table 139. North America Sepsis Detection Kit Consumption Value by Country (2021-2026) & (USD Million)
Table 140. North America Sepsis Detection Kit Consumption Value by Country (2027-2032) & (USD Million)
Table 141. Europe Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 142. Europe Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 143. Europe Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 144. Europe Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 145. Europe Sepsis Detection Kit Sales Quantity by Country (2021-2026) & (K Units)
Table 146. Europe Sepsis Detection Kit Sales Quantity by Country (2027-2032) & (K Units)
Table 147. Europe Sepsis Detection Kit Consumption Value by Country (2021-2026) & (USD Million)
Table 148. Europe Sepsis Detection Kit Consumption Value by Country (2027-2032) & (USD Million)
Table 149. Asia-Pacific Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 150. Asia-Pacific Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 151. Asia-Pacific Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 152. Asia-Pacific Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 153. Asia-Pacific Sepsis Detection Kit Sales Quantity by Region (2021-2026) & (K Units)
Table 154. Asia-Pacific Sepsis Detection Kit Sales Quantity by Region (2027-2032) & (K Units)
Table 155. Asia-Pacific Sepsis Detection Kit Consumption Value by Region (2021-2026) & (USD Million)
Table 156. Asia-Pacific Sepsis Detection Kit Consumption Value by Region (2027-2032) & (USD Million)
Table 157. South America Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 158. South America Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 159. South America Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 160. South America Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 161. South America Sepsis Detection Kit Sales Quantity by Country (2021-2026) & (K Units)
Table 162. South America Sepsis Detection Kit Sales Quantity by Country (2027-2032) & (K Units)
Table 163. South America Sepsis Detection Kit Consumption Value by Country (2021-2026) & (USD Million)
Table 164. South America Sepsis Detection Kit Consumption Value by Country (2027-2032) & (USD Million)
Table 165. Middle East & Africa Sepsis Detection Kit Sales Quantity by Type (2021-2026) & (K Units)
Table 166. Middle East & Africa Sepsis Detection Kit Sales Quantity by Type (2027-2032) & (K Units)
Table 167. Middle East & Africa Sepsis Detection Kit Sales Quantity by Application (2021-2026) & (K Units)
Table 168. Middle East & Africa Sepsis Detection Kit Sales Quantity by Application (2027-2032) & (K Units)
Table 169. Middle East & Africa Sepsis Detection Kit Sales Quantity by Country (2021-2026) & (K Units)
Table 170. Middle East & Africa Sepsis Detection Kit Sales Quantity by Country (2027-2032) & (K Units)
Table 171. Middle East & Africa Sepsis Detection Kit Consumption Value by Country (2021-2026) & (USD Million)
Table 172. Middle East & Africa Sepsis Detection Kit Consumption Value by Country (2027-2032) & (USD Million)
Table 173. Sepsis Detection Kit Raw Material
Table 174. Key Manufacturers of Sepsis Detection Kit Raw Materials
Table 175. Sepsis Detection Kit Typical Distributors
Table 176. Sepsis Detection Kit Typical Customers
LIST OF FIGURES
Figure 1. Sepsis Detection Kit Picture
Figure 2. Global Sepsis Detection Kit Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Sepsis Detection Kit Revenue Market Share by Type in 2025
Figure 4. Immunochromatography Examples
Figure 5. Molecular Biology Examples
Figure 6. Global Sepsis Detection Kit Revenue by Detection Target, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Sepsis Detection Kit Revenue Market Share by Detection Target in 2025
Figure 8. Single Biomarker Examples
Figure 9. Multi-indicator Combined Detection Examples
Figure 10. Global Sepsis Detection Kit Revenue by Detection Time, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Sepsis Detection Kit Revenue Market Share by Detection Time in 2025
Figure 12. ≤30 minutes Examples
Figure 13. 0.5~4 hours Examples
Figure 14. ≥4 hours Examples
Figure 15. Global Sepsis Detection Kit Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Sepsis Detection Kit Revenue Market Share by Application in 2025
Figure 17. General Hospitals Examples
Figure 18. Medical Laboratory (ICL) Industry Examples
Figure 19. Maternal and Child Health Industry Examples
Figure 20. Others Examples
Figure 21. Global Sepsis Detection Kit Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Sepsis Detection Kit Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Sepsis Detection Kit Sales Quantity (2021-2032) & (K Units)
Figure 24. Global Sepsis Detection Kit Price (2021-2032) & (US$/Unit)
Figure 25. Global Sepsis Detection Kit Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Sepsis Detection Kit Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Sepsis Detection Kit by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Sepsis Detection Kit Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Sepsis Detection Kit Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Sepsis Detection Kit Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Sepsis Detection Kit Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Sepsis Detection Kit Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Sepsis Detection Kit Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. Global Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Sepsis Detection Kit Revenue Market Share by Application (2021-2032)
Figure 42. Global Sepsis Detection Kit Average Price by Application (2021-2032) & (US$/Unit)
Figure 43. North America Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Sepsis Detection Kit Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Sepsis Detection Kit Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Sepsis Detection Kit Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Sepsis Detection Kit Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 55. France Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Sepsis Detection Kit Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Sepsis Detection Kit Consumption Value Market Share by Region (2021-2032)
Figure 63. China Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 66. India Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Sepsis Detection Kit Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Sepsis Detection Kit Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Sepsis Detection Kit Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Sepsis Detection Kit Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 83. Sepsis Detection Kit Market Drivers
Figure 84. Sepsis Detection Kit Market Restraints
Figure 85. Sepsis Detection Kit Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Sepsis Detection Kit in 2025
Figure 88. Manufacturing Process Analysis of Sepsis Detection Kit
Figure 89. Sepsis Detection Kit Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
Figure 1. Sepsis Detection Kit Picture
Figure 2. Global Sepsis Detection Kit Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Sepsis Detection Kit Revenue Market Share by Type in 2025
Figure 4. Immunochromatography Examples
Figure 5. Molecular Biology Examples
Figure 6. Global Sepsis Detection Kit Revenue by Detection Target, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Sepsis Detection Kit Revenue Market Share by Detection Target in 2025
Figure 8. Single Biomarker Examples
Figure 9. Multi-indicator Combined Detection Examples
Figure 10. Global Sepsis Detection Kit Revenue by Detection Time, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Sepsis Detection Kit Revenue Market Share by Detection Time in 2025
Figure 12. ≤30 minutes Examples
Figure 13. 0.5~4 hours Examples
Figure 14. ≥4 hours Examples
Figure 15. Global Sepsis Detection Kit Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Sepsis Detection Kit Revenue Market Share by Application in 2025
Figure 17. General Hospitals Examples
Figure 18. Medical Laboratory (ICL) Industry Examples
Figure 19. Maternal and Child Health Industry Examples
Figure 20. Others Examples
Figure 21. Global Sepsis Detection Kit Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Sepsis Detection Kit Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Sepsis Detection Kit Sales Quantity (2021-2032) & (K Units)
Figure 24. Global Sepsis Detection Kit Price (2021-2032) & (US$/Unit)
Figure 25. Global Sepsis Detection Kit Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Sepsis Detection Kit Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Sepsis Detection Kit by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Sepsis Detection Kit Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Sepsis Detection Kit Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Sepsis Detection Kit Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Sepsis Detection Kit Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Sepsis Detection Kit Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Sepsis Detection Kit Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. Global Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Sepsis Detection Kit Revenue Market Share by Application (2021-2032)
Figure 42. Global Sepsis Detection Kit Average Price by Application (2021-2032) & (US$/Unit)
Figure 43. North America Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Sepsis Detection Kit Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Sepsis Detection Kit Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Sepsis Detection Kit Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Sepsis Detection Kit Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 55. France Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Sepsis Detection Kit Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Sepsis Detection Kit Consumption Value Market Share by Region (2021-2032)
Figure 63. China Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 66. India Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Sepsis Detection Kit Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Sepsis Detection Kit Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Sepsis Detection Kit Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Sepsis Detection Kit Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Sepsis Detection Kit Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Sepsis Detection Kit Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Sepsis Detection Kit Consumption Value (2021-2032) & (USD Million)
Figure 83. Sepsis Detection Kit Market Drivers
Figure 84. Sepsis Detection Kit Market Restraints
Figure 85. Sepsis Detection Kit Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Sepsis Detection Kit in 2025
Figure 88. Manufacturing Process Analysis of Sepsis Detection Kit
Figure 89. Sepsis Detection Kit Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
